Skip to main content
PMC home page
Thorax logoLink to Thorax
. 2001 Sep;56(9):713–720. doi: 10.1136/thorax.56.9.713

Alternative methods for assessing bronchodilator reversibility in chronic obstructive pulmonary disease

J Hadcroft 1, P Calverley 1
PMCID: PMC1746134  PMID: 11514693

Abstract

BACKGROUND—Bronchodilator reversibility testing is recommended in all patients with chronic obstructive pulmonary disease (COPD) but does not predict improvements in breathlessness or exercise performance. Two alternative ways of assessing lung mechanics—measurement of end expiratory lung volume (EELV) using the inspiratory capacity manoeuvre and application of negative expiratory pressure (NEP) during tidal breathing to detect tidal airflow limitation—do relate to the degree of breathlessness in COPD. Their usefulness as end points in bronchodilator reversibility testing has not been examined.
METHODS—We studied 20 patients with clinically stable COPD (mean age 69.9 (1.5) years, 15 men, forced expiratory volume in one second (FEV1) 29.5 (1.6)% predicted) with tidal flow limitation as assessed by their maximum flow-volume loop. Spirometric parameters, slow vital capacity (SVC), inspiratory capacity (IC), and NEP were measured seated, before and after nebulised saline, and at intervals after 5 mg nebulised salbutamol and 500 µg nebulised ipratropium bromide. The patients attended twice and the treatment order was randomised.
RESULTS—Mean FEV1, FVC, SVC, and IC were unchanged after saline but the degree of tidal flow limitation varied. FEV1 improved significantly after salbutamol and ipratropium (0.11 (0.02) l and 0.09 (0.02) l, respectively) as did the other lung volumes with further significant increases after the combination. Tidal volume and mean expiratory flow increased significantly after all bronchodilators but breathlessness fell significantly only after the combination treatment. The initial NEP score was unrelated to subsequent changes in lung volume.
CONCLUSIONS—NEP is not an appropriate measurement of acute bronchodilator responsiveness. Changes in IC were significantly larger than those in FEV1 and may be more easily detected. However, our data showed no evidence for separation of "reversible" and "irreversible" groups whatever outcome measure was adopted.



Full Text

The Full Text of this article is available as a PDF (165.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Anthonisen N. R., Wright E. C., Hodgkin J. E. Prognosis in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1986 Jan;133(1):14–20. doi: 10.1164/arrd.1986.133.1.14. [DOI] [PubMed] [Google Scholar]
  2. Belman M. J., Botnick W. C., Shin J. W. Inhaled bronchodilators reduce dynamic hyperinflation during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996 Mar;153(3):967–975. doi: 10.1164/ajrccm.153.3.8630581. [DOI] [PubMed] [Google Scholar]
  3. Black L. F., Hyatt R. E. Maximal respiratory pressures: normal values and relationship to age and sex. Am Rev Respir Dis. 1969 May;99(5):696–702. doi: 10.1164/arrd.1969.99.5.696. [DOI] [PubMed] [Google Scholar]
  4. Boczkowski J., Murciano D., Pichot M. H., Ferretti A., Pariente R., Milic-Emili J. Expiratory flow limitation in stable asthmatic patients during resting breathing. Am J Respir Crit Care Med. 1997 Sep;156(3 Pt 1):752–757. doi: 10.1164/ajrccm.156.3.9609083. [DOI] [PubMed] [Google Scholar]
  5. Borg G. A. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14(5):377–381. [PubMed] [Google Scholar]
  6. D'Angelo E., Milic-Emili J., Marazzini L. Effects of bronchomotor tone and gas density on time dependence of forced expiratory vital capacity maneuver. Am J Respir Crit Care Med. 1996 Nov;154(5):1318–1322. doi: 10.1164/ajrccm.154.5.8912742. [DOI] [PubMed] [Google Scholar]
  7. Eltayara L., Becklake M. R., Volta C. A., Milic-Emili J. Relationship between chronic dyspnea and expiratory flow limitation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1996 Dec;154(6 Pt 1):1726–1734. doi: 10.1164/ajrccm.154.6.8970362. [DOI] [PubMed] [Google Scholar]
  8. Gross N. J., Skorodin M. S. Role of the parasympathetic system in airway obstruction due to emphysema. N Engl J Med. 1984 Aug 16;311(7):421–425. doi: 10.1056/NEJM198408163110701. [DOI] [PubMed] [Google Scholar]
  9. Hay J. G., Stone P., Carter J., Church S., Eyre-Brook A., Pearson M. G., Woodcock A. A., Calverley P. M. Bronchodilator reversibility, exercise performance and breathlessness in stable chronic obstructive pulmonary disease. Eur Respir J. 1992 Jun;5(6):659–664. [PubMed] [Google Scholar]
  10. Jones P. W., Quirk F. H., Baveystock C. M., Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis. 1992 Jun;145(6):1321–1327. doi: 10.1164/ajrccm/145.6.1321. [DOI] [PubMed] [Google Scholar]
  11. Koulouris N. G., Valta P., Lavoie A., Corbeil C., Chassé M., Braidy J., Milic-Emili J. A simple method to detect expiratory flow limitation during spontaneous breathing. Eur Respir J. 1995 Feb;8(2):306–313. doi: 10.1183/09031936.95.08020306. [DOI] [PubMed] [Google Scholar]
  12. Nisar M., Earis J. E., Pearson M. G., Calverley P. M. Acute bronchodilator trials in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1992 Sep;146(3):555–559. doi: 10.1164/ajrccm/146.3.555. [DOI] [PubMed] [Google Scholar]
  13. O'Donnell D. E., Bain D. J., Webb K. A. Factors contributing to relief of exertional breathlessness during hyperoxia in chronic airflow limitation. Am J Respir Crit Care Med. 1997 Feb;155(2):530–535. doi: 10.1164/ajrccm.155.2.9032190. [DOI] [PubMed] [Google Scholar]
  14. O'Donnell D. E., Lam M., Webb K. A. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1999 Aug;160(2):542–549. doi: 10.1164/ajrccm.160.2.9901038. [DOI] [PubMed] [Google Scholar]
  15. O'Donnell D. E., Webb K. A. Breathlessness in patients with severe chronic airflow limitation. Physiologic correlations. Chest. 1992 Sep;102(3):824–831. doi: 10.1378/chest.102.3.824. [DOI] [PubMed] [Google Scholar]
  16. Pellegrino R., Brusasco V. Lung hyperinflation and flow limitation in chronic airway obstruction. Eur Respir J. 1997 Mar;10(3):543–549. [PubMed] [Google Scholar]
  17. Pellegrino R., Rodarte J. R., Brusasco V. Assessing the reversibility of airway obstruction. Chest. 1998 Dec;114(6):1607–1612. doi: 10.1378/chest.114.6.1607. [DOI] [PubMed] [Google Scholar]
  18. Quanjer P. H., Tammeling G. J., Cotes J. E., Pedersen O. F., Peslin R., Yernault J. C. Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society. Eur Respir J Suppl. 1993 Mar;16:5–40. [PubMed] [Google Scholar]
  19. Siafakas N. M., Vermeire P., Pride N. B., Paoletti P., Gibson J., Howard P., Yernault J. C., Decramer M., Higenbottam T., Postma D. S. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). The European Respiratory Society Task Force. Eur Respir J. 1995 Aug;8(8):1398–1420. doi: 10.1183/09031936.95.08081398. [DOI] [PubMed] [Google Scholar]
  20. Sourk R. L., Nugent K. M. Bronchodilator testing: confidence intervals derived from placebo inhalations. Am Rev Respir Dis. 1983 Jul;128(1):153–157. doi: 10.1164/arrd.1983.128.1.153. [DOI] [PubMed] [Google Scholar]
  21. Spence D. P., Kelly Y. J., Ahmed J., Calverley P. M., Pearson M. G. Critical evaluation of computerised x ray planimetry for the measurement of lung volumes. Thorax. 1995 Apr;50(4):383–386. doi: 10.1136/thx.50.4.383. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Tantucci C., Duguet A., Similowski T., Zelter M., Derenne J. P., Milic-Emili J. Effect of salbutamol on dynamic hyperinflation in chronic obstructive pulmonary disease patients. Eur Respir J. 1998 Oct;12(4):799–804. doi: 10.1183/09031936.98.12040799. [DOI] [PubMed] [Google Scholar]
  23. Teale C., Morrison J. F., Jones P. C., Muers M. F. Reversibility tests in chronic obstructive airways disease: their predictive value with reference to benefit from domiciliary nebuliser therapy. Respir Med. 1991 Jul;85(4):281–284. doi: 10.1016/s0954-6111(06)80097-1. [DOI] [PubMed] [Google Scholar]
  24. Tweeddale P. M., Alexander F., McHardy G. J. Short term variability in FEV1 and bronchodilator responsiveness in patients with obstructive ventilatory defects. Thorax. 1987 Jul;42(7):487–490. doi: 10.1136/thx.42.7.487. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Vathenen A. S., Britton J. R., Ebden P., Cookson J. B., Wharrad H. J., Tattersfield A. E. High-dose inhaled albuterol in severe chronic airflow limitation. Am Rev Respir Dis. 1988 Oct;138(4):850–855. doi: 10.1164/ajrccm/138.4.850. [DOI] [PubMed] [Google Scholar]
  26. Yan S., Kaminski D., Sliwinski P. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1997 Jul;156(1):55–59. doi: 10.1164/ajrccm.156.1.9608113. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES